Sign Up

KRRO

COM:KORROBIO

Korro Bio

  • Stock

USD

Last Close

50.62

22/11 21:00

Market Cap

385.94M

Beta: -

Volume Today

67.40K

Avg: -

OverviewAnalysisMetricsFinancialsFilingsAPIChartData
Income StatementBalance SheetCash FlowKey MetricsRatios
Quarterly
Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '21
Dec '22
Dec '23
average inventory
-72K
-
-72K
0%
average payables
3.15M
-
1.70M
46.08%
4.94M
191.25%
average receivables
242K
-
72K
70.25%
book value per share
-5.28
-
-12.38
134.63%
111.10
997.66%
capex per share
-0.56
-
-0.65
17.20%
-5.12
686.59%
capex to depreciation
-2.79
-
-2.08
25.55%
-2.16
4.00%
capex to operating cash flow
0.14
-
0.10
29.88%
0.12
19.87%
capex to revenue
-0.32
-
cash per share
14.81
-
6.90
53.39%
108.64
1,473.42%
days of inventory on hand
-13.68
-
days payables outstanding
74.98
-
378.66
405.04%
732.01
93.31%
days sales outstanding
3.74
-
debt to assets
0.13
-
0.04
67.67%
0.15
252.94%
debt to equity
-0.40
-
-0.03
92.03%
0.20
718.35%
dividend yield
earnings yield
-0.01
-
-0.04
252.14%
-1.08
2,766.79%
enterprise value
2.01B
-
1.51B
25.19%
-57.79M
103.83%
enterprise value over ebitda
-59.42
-
-26.68
55.10%
0.71
102.68%
ev to operating cash flow
-62.77
-
-28.09
55.24%
0.86
103.06%
ev to sales
143.19
-
free cash flow per share
-4.57
-
-7.36
61.07%
-49.12
567.75%
free cash flow yield
-0.02
-
-0.04
114.62%
-1.00
2,515.82%
graham net net
-6.40
-
-14.69
129.47%
74.80
609.27%
graham number
18.05
-
44.94
149.01%
364.26
710.50%
income quality
1.46
-
0.92
36.75%
0.83
10.33%
intangibles to total assets
0
-
0
0
interest coverage
-499.98
-
interest debt per share
2.09
-
0.41
80.61%
21.71
5,249.02%
inventory turnover
-26.67
-
invested capital
-0.40
-
-0.03
92.03%
0.20
718.35%
market cap
2.05B
-
1.54B
24.95%
75.15M
95.12%
net current asset value
-50.01M
-
-115.69M
131.34%
120.98M
204.57%
net debt to ebitda
1.12
-
0.59
47.42%
1.64
179.55%
net income per share
-2.74
-
-7.25
164.27%
-53.08
631.81%
operating cash flow per share
-4.01
-
-6.70
67.15%
-44.00
556.20%
payables turnover
4.87
-
0.96
80.20%
0.50
48.27%
receivables turnover
97.69
-
research and ddevelopement to revenue
1.69
-
return on tangible assets
-0.17
-
-0.79
357.20%
-0.37
53.47%
revenue per share
1.76
-
roe
0.52
-
0.59
12.64%
-0.48
181.52%
roic
-10.47
-
0.64
106.07%
-0.36
156.26%
sales general and administrative to revenue
0.83
-
shareholders equity per share
-5.28
-
-12.38
134.63%
111.10
997.66%
stock based compensation to revenue
0.06
-
tangible asset value
-42.21M
-
-99.03M
134.63%
169.91M
271.57%
tangible book value per share
-5.28
-
-12.38
134.63%
111.10
997.66%
working capital
114.83M
-
48.38M
57.86%
153.25M
216.74%

All numbers in USD (except ratios and percentages)